Obesity and insulin resistance

Journal of Clinical Investigation

Volumn 106, Issue 4, 2000, Pages 473-481

  Kahn, Barbara B ^a   Flier, Jeffrey S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; BODY FAT; DRUG MECHANISM; ENDOCRINE CELL; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPOATROPHY; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033849777     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10842     Document Type: Review

References (56)

1. Reaven, G.M. 1995. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75:473-486.
2. Paradis, S., and Ruvkun, G. 1998. Caenorhabditis elegans Akt PKB transduces insulin receptor-like signals from AGE-1 P13 kinase to the DAF-16 transcription factor. Genes Dev. 12:2488-2498.
3. White, M.F. 1998. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog. Horm. Res. 53:119-138.
4. Staubs, P.A., Nelson, J.G., Reichart, D.R., and Olefsky, J.M. 1998. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J. Biol. Chem. 273:25139-25147.
5. Czech, M.P., and Corvera, S. 1999. Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274:1865-1868.
6. Wang, Q., et al. 1999. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19:4008-4018.
7. Kitamura, T., et al. 1998. Requirement for activation of the serine-threonine kinase akt (Protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18:3708-3717.
8. Kotani, K., et al. 1998. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 18:6971-6982.
9. Kitamura, T., et al. 1999. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19:6286-6296.
10. Kim, J.B., et al. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD-1/SREBP1. J. Clin. Invest. 101:1-9.
11. Shimomura, I., et al. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA. 96:13656-13661.
12. Foretz, M., Guichard, C. Ferré, P., and Foufelle, F. 1999. Sterol regulatory binding element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA. 96:12737-12742.
13. Kops, G.J., and Burgering, B.M. 1999. Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J. Mol. Med. 77:656-665.
14. Rondinone, C.M., et al. 1997. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 94:4171-4175.
15. Kim, Y.B., Nikoulina, S.E., Ciaraldi, T.P., Henry, R.R., and Kahn, B.B. 1999. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J. Clin. Invest. 104:733-741.
16. Goldstein, B.J., Ahmad, F., Ding, W., Li, P.M., and Zhang, W.R. 1998. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol. Cell. Biochem. 182:91-99.
17. Goldstein, B.J., Bittner-Kowalczyk, A., White, M.F., and Harbeck, M. 2000. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the grb2 adaptor protein. J. Biol. Chem. 275:4283-4289.
18. Elchebly, M., et al. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 283:1544-1548.
19. Klaman, L.D., et al. 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B (PTP1B)-deficient mice. Mol. Cell. Biol. 20:5479-5489.
20. Goodyear, L.J., et al. 1995. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95:2195-2204.
21. Shepherd, P.R., and Kahn, B.B. 1999. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341:248-257.
22. Kraegen, E.W., James, D.E., Jenkins, A.B., and Chisholm, D.J. 1985. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am. J. Physiol. 248:E353-E362.
23. Shepherd, P.R., et al. 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268:22243-22246.
24. Tozzo, E., Gnudi, L., and Kahn, B.B. 1997. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology. 138:1604-1611.
25. de Souza, C.J., Hirshman, M.F., and Horton, E.S. 1997. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes. 46:1257-1263.
26. Weyer, C., Tataranni, P.A., Snitker, S., Danforth, E., Jr., and Ravussin, E. 1998. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes. 47:1555-1561.
27. Colditz, G.A., et al. 1990. Weight as a risk factor for clinical diabetes in women. Am. J. Epidemiol. 132:501-513.
28. Kissebah, A.H., and Krakower, G.R. 1994. Regional adiposity and morbidity. Physiol. Rev. 74:761-811.
29. Patti, M.E., and Kahn, C.R. 1996. Lessons from transgenic and knockout animals about noninsulin-dependent diabetes mellitus. Trends Endocrinol. Metab. 7:311-319.
30. Bujalska, I.J., Kumar, S., and Stewart, P.M. 1997. Does central obesity reflect "Cushing's disease of the ometum"? Lancet. 349:1210-1213.
31. Deslypere, J.P., Verdonck, L., and Vermeulen, A., 1985. Fat tissue: a steroid reservoir and site of steroid metabolism. J. Clin. Endocrinol. Metab. 61:564-570.
32. Peraldi, P., and Spiegelman, B. 1998. TNF-alpba and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 182:169-175.
33. Hotamisligil, G.S., 1999. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245:621-625.
34. Friedman, J.M. 2000. Obesity in the new millenium. Nature. 404:632-634.
35. Flier, J.S. 1998. What's in a name? In seach of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83-1407-1413.
36. Elmquist, J.K., Maratos-Flier, E., Saper, C.B., and Flier, J.S. 1998. Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci. 1:445-450.
37. Halaas, J.L., et al. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543-546.
38. Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R., and Burn, P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-549.
39. Pelleymounter, M.A., et al. 1995. Effects of the obese gene product on body weight regualtion in ob/ob mice. Science. 269:540-543.
40. Bray, G.A. 1985. Autonomic and endocrine factors in the regultion of food intake. Brain Res. Bull. 14:505-510.
41. Kamoharra, S., Burcelin, R., Halaas, J.L., Friedman, J.M., Charron, M.J. 1997. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 389:374-377.
42. Kim, Y.-B., Uotani, S., Pierroz, D.D., Flier, J.S., and Kahn, B.B. 2000. In vivo administration of leptin activates signal transduction directly in insulin sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology. 141:2328-2339.
43. Muoio, D.M., Dohm, G.L., Fiedorek, F., Jr., Tapscott, E.B., and Coleman, R.A. 1997. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes. 46:1360-1363.
44. Shimabukuro, M., et al. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA. 94:4637-4641.
45. Wang, J., Liu, R., Hawkins, M., Barzilai, N., and Rossetti, L., 1998. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 393:684-688.
46. Montague, C.T., et al. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:903-908.
47. Clement, K., et al. 1998. A mutation in the human leptin receptor gene caused obesity and pituitary dysfunction. Nature 392:398-401.
48. Griffin. et al. 1999. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1270-1274.
49. Zierath, J.R., Houseknecht, K.L., Gnudi, L., and Kahn, B.B. 1997. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes. 46:215-223.
50. Borkman, M., et al. 1993. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328:238-244.
51. Shimabukuro, M., et al. 1998. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273:32487-32490.
52. Shimomura, I., Hammer, R.E., Ikemoto, S., Brown, M.S., and Goldstein, J.L. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 401:73-76.
53. Gavrilova, O., et al. 2000. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J. Clin. Invest. 105:271-278.
54. Ogawa, Y., et al. 1999. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes. 48:1822-1829.
55. Unger, R.H., Zhou, Y.T., and Orci, L. 1999. Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Nalt. Acad. Sci. USA. 96:2327-2332.
56. Olefsky, J.M. 2000. Treatment of insulin resistance with peroxisome proliferator activated rereptor γ agonists. J. Clin. Invest. 106:467-472.